News|Videos|June 13, 2023
Transduction for AAV with Sean Hart
Author(s)Chris Spivey
Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured.
Advertisement
Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured. The full discussion can and more can be viewed
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What Does Overton's FDA Nomination Mean for Drug Reviews?
2
Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models
3
PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers
4
Ecopipam's D1 Receptor Approach Signals New Pediatric Neuroscience Pathway
5